| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 9.810 | 27.717 | 25.308 | 18.976 | 18.930 | 30.603 | 37.275 | 48.011 | 59.376 |
| Total Income - EUR | - | 9.810 | 27.717 | 25.308 | 18.976 | 18.930 | 30.603 | 37.275 | 48.011 | 59.376 |
| Total Expenses - EUR | - | 4.340 | 7.104 | 8.070 | 9.179 | 4.166 | 2.679 | 6.834 | 9.929 | 11.013 |
| Gross Profit/Loss - EUR | - | 5.470 | 20.613 | 17.238 | 9.797 | 14.765 | 27.924 | 30.441 | 38.082 | 48.363 |
| Net Profit/Loss - EUR | - | 5.274 | 20.336 | 16.985 | 9.607 | 14.352 | 27.022 | 29.680 | 37.612 | 46.618 |
| Employees | - | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
Check the financial reports for the company - Epure Medcons Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 1.009 | 748 | 483 | 218 |
| Current Assets | - | 6.002 | 21.076 | 17.751 | 10.570 | 19.720 | 26.475 | 34.938 | 38.001 | 48.090 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 581 | 4.189 | 4.109 | 4.476 | 3.690 | 8.941 | 32.138 | 31.105 | 36.761 |
| Cash | - | 5.422 | 16.887 | 13.642 | 6.093 | 16.030 | 17.534 | 2.800 | 6.896 | 11.329 |
| Shareholders Funds | - | 5.318 | 20.388 | 17.036 | 9.658 | 19.688 | 27.070 | 29.728 | 37.660 | 46.666 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 684 | 688 | 715 | 912 | 41 | 414 | 5.969 | 877 | 1.814 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Epure Medcons Srl